These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22283811)

  • 1. Editorial: TB drug development.
    Aldrich CC
    Curr Top Med Chem; 2012; 12(7):671. PubMed ID: 22283811
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel proteasome inhibitors as potential drugs to combat tuberculosis.
    Cheng Y; Pieters J
    J Mol Cell Biol; 2010 Aug; 2(4):173-5. PubMed ID: 20123700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium tuberculosis gyrase inhibitors as a new class of antitubercular drugs.
    Blanco D; Perez-Herran E; Cacho M; Ballell L; Castro J; González Del Río R; Lavandera JL; Remuiñán MJ; Richards C; Rullas J; Vázquez-Muñiz MJ; Woldu E; Zapatero-González MC; Angulo-Barturen I; Mendoza A; Barros D
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1868-75. PubMed ID: 25583730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis drug resistance mutation database.
    Sandgren A; Strong M; Muthukrishnan P; Weiner BK; Church GM; Murray MB
    PLoS Med; 2009 Feb; 6(2):e2. PubMed ID: 19209951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiology. TB--a new target, a new drug.
    Cole ST; Alzari PM
    Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490
    [No Abstract]   [Full Text] [Related]  

  • 6. The future for early-stage tuberculosis drug discovery.
    Zuniga ES; Early J; Parish T
    Future Microbiol; 2015; 10(2):217-29. PubMed ID: 25689534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relevance of persisters in tuberculosis drug discovery.
    Mandal S; Njikan S; Kumar A; Early JV; Parish T
    Microbiology (Reading); 2019 May; 165(5):492-499. PubMed ID: 30775961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current challenges in drug discovery for tuberculosis.
    Kumar A; Chettiar S; Parish T
    Expert Opin Drug Discov; 2017 Jan; 12(1):1-4. PubMed ID: 27797593
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitubercular activity of disulfiram, an antialcoholism drug, against multidrug- and extensively drug-resistant Mycobacterium tuberculosis isolates.
    Horita Y; Takii T; Yagi T; Ogawa K; Fujiwara N; Inagaki E; Kremer L; Sato Y; Kuroishi R; Lee Y; Makino T; Mizukami H; Hasegawa T; Yamamoto R; Onozaki K
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4140-5. PubMed ID: 22615274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New tuberculosis drugs on the horizon.
    Cole ST; Riccardi G
    Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of novel drug targets in Mycobacterium tuberculosis.
    Singh V; Mizrahi V
    Drug Discov Today; 2017 Mar; 22(3):503-509. PubMed ID: 27649943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets.
    Hudson SA; McLean KJ; Munro AW; Abell C
    Biochem Soc Trans; 2012 Jun; 40(3):573-9. PubMed ID: 22616869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets.
    Dos Santos Fernandes GF; Jornada DH; de Souza PC; Chin CM; Pavan FR; Dos Santos JL
    Curr Med Chem; 2015; 22(27):3133-61. PubMed ID: 26282941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colworth prize lecture 2016: exploiting new biological targets from a whole-cell phenotypic screening campaign for TB drug discovery.
    Moynihan PJ; Besra GS
    Microbiology (Reading); 2017 Oct; 163(10):1385-1388. PubMed ID: 28893361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Accidental discoveries, different mechanisms of action. Active agents against Mycobacterium tuberculosis in clinical application].
    Weeken D; Schlitzer M
    Pharm Unserer Zeit; 2012 Jan; 41(1):35-47. PubMed ID: 22470917
    [No Abstract]   [Full Text] [Related]  

  • 16. The quest for the holy grail: new antitubercular chemical entities, targets and strategies.
    Huszár S; Chibale K; Singh V
    Drug Discov Today; 2020 Apr; 25(4):772-780. PubMed ID: 32062007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
    Sharma A; Khuller GK; Sharma S
    Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Affairs, Future Perspectives of Tuberculosis and Antitubercular Agents.
    Gawad J; Bonde C
    Indian J Tuberc; 2018 Jan; 65(1):15-22. PubMed ID: 29332642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Welcome to 'Tuberculosis drug discovery and development'.
    D'Oca G
    Future Med Chem; 2010 Aug; 2(8):1241-2. PubMed ID: 21426014
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycobacterium tuberculosis-Secreted Tyrosine Phosphatases as Targets Against Tuberculosis: Exploring Natural Sources in Searching for New Drugs.
    Mascarello A; Chiaradia-Delatorre LD; Mori M; Terenzi H; Botta B
    Curr Pharm Des; 2016; 22(12):1561-9. PubMed ID: 26759082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.